Case study: The New Pharmacy, Part 4

Case study: The New Pharmacy, Part 4

[...]by fixing your digestion, we will prevent the translocation of foreign proteins through your onecell-thick colon wall into your bloodstream. [...]gel your 1,25-OH vitamin D level (goal is 50-80 ng/mL); get an HbAlc done (goal is

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drug Topics 2015-11, Vol.159 (11), p.14
1. Verfasser: Burger, Mark T
Format: Artikel
Sprache:eng
Schlagworte:
Colon
Eczema
Enzymes
Food
Gastroesophageal reflux
Gluten
Hydrochloric acid
Insulin
Irritable bowel syndrome
Lipids
Metabolism
Patients
Probiotics
Proteins
Psoriasis
Studies
Vitamin D
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 11
container_start_page 14
container_title Drug Topics
container_volume 159
creator Burger, Mark T
description [...]by fixing your digestion, we will prevent the translocation of foreign proteins through your onecell-thick colon wall into your bloodstream. [...]gel your 1,25-OH vitamin D level (goal is 50-80 ng/mL); get an HbAlc done (goal is
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_reports_1803533480</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4115649901</sourcerecordid><originalsourceid>FETCH-proquest_reports_18035334803</originalsourceid><addsrcrecordid>eNpjYuA0tDQ217UwNDVnYeA0MDA00jUzMzTjYOAqLs4yMDAwMTM152RQcU4sTlUoLilNqbRSCMlIVfBLLVcIyEgsyk1MrtRRCEgsKlEw4WFgTUvMKU7lhdLcDEpuriHOHroFRfmFpanFJfFFqQX5RSXF8YYWBsamxsYmQIooRQCbHi2a</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1803533480</pqid></control><display><type>article</type><title>Case study: The New Pharmacy, Part 4</title><source>Alma/SFX Local Collection</source><creator>Burger, Mark T</creator><creatorcontrib>Burger, Mark T</creatorcontrib><description>[...]by fixing your digestion, we will prevent the translocation of foreign proteins through your onecell-thick colon wall into your bloodstream. [...]gel your 1,25-OH vitamin D level (goal is 50-80 ng/mL); get an HbAlc done (goal is &lt;5.3%); ask your doctor to order an Lp(a), oxidized cholesterol, and find out your ApoB-gene status." [...]look at how many surrogate markers, how much mood enhancement and metabolic balance we get just by correcting digestion: lipids, immune modulation (T-helper cell ratio/B-cell levels), psoriasis, cardiovascular (sugar damages endothelium, cholesterol rises to patch the damage); GERD; IBS-D; normalized stress hormone(s); maybe an increase in endogenous testosterone and/or increased sensitivity of T-receptors as cortisol levels normalize.</description><identifier>ISSN: 0012-6616</identifier><identifier>EISSN: 1937-8157</identifier><identifier>CODEN: DGTNA7</identifier><language>eng</language><publisher>Monmouth Junction: MultiMedia Healthcare Inc</publisher><subject>Colon ; Eczema ; Enzymes ; Food ; Gastroesophageal reflux ; Gluten ; Hydrochloric acid ; Insulin ; Irritable bowel syndrome ; Lipids ; Metabolism ; Patients ; Probiotics ; Proteins ; Psoriasis ; Studies ; Vitamin D</subject><ispartof>Drug Topics, 2015-11, Vol.159 (11), p.14</ispartof><rights>Copyright Advanstar Communications, Inc. Nov 2015</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>312,780,784,791</link.rule.ids></links><search><creatorcontrib>Burger, Mark T</creatorcontrib><title>Case study: The New Pharmacy, Part 4</title><title>Drug Topics</title><description>[...]by fixing your digestion, we will prevent the translocation of foreign proteins through your onecell-thick colon wall into your bloodstream. [...]gel your 1,25-OH vitamin D level (goal is 50-80 ng/mL); get an HbAlc done (goal is &lt;5.3%); ask your doctor to order an Lp(a), oxidized cholesterol, and find out your ApoB-gene status." [...]look at how many surrogate markers, how much mood enhancement and metabolic balance we get just by correcting digestion: lipids, immune modulation (T-helper cell ratio/B-cell levels), psoriasis, cardiovascular (sugar damages endothelium, cholesterol rises to patch the damage); GERD; IBS-D; normalized stress hormone(s); maybe an increase in endogenous testosterone and/or increased sensitivity of T-receptors as cortisol levels normalize.</description><subject>Colon</subject><subject>Eczema</subject><subject>Enzymes</subject><subject>Food</subject><subject>Gastroesophageal reflux</subject><subject>Gluten</subject><subject>Hydrochloric acid</subject><subject>Insulin</subject><subject>Irritable bowel syndrome</subject><subject>Lipids</subject><subject>Metabolism</subject><subject>Patients</subject><subject>Probiotics</subject><subject>Proteins</subject><subject>Psoriasis</subject><subject>Studies</subject><subject>Vitamin D</subject><issn>0012-6616</issn><issn>1937-8157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpjYuA0tDQ217UwNDVnYeA0MDA00jUzMzTjYOAqLs4yMDAwMTM152RQcU4sTlUoLilNqbRSCMlIVfBLLVcIyEgsyk1MrtRRCEgsKlEw4WFgTUvMKU7lhdLcDEpuriHOHroFRfmFpanFJfFFqQX5RSXF8YYWBsamxsYmQIooRQCbHi2a</recordid><startdate>20151101</startdate><enddate>20151101</enddate><creator>Burger, Mark T</creator><general>MultiMedia Healthcare Inc</general><scope>0U~</scope><scope>1-H</scope><scope>3V.</scope><scope>7RQ</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>883</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K60</scope><scope>K6~</scope><scope>K9.</scope><scope>L.-</scope><scope>L.0</scope><scope>M0C</scope><scope>M0F</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>U9A</scope></search><sort><creationdate>20151101</creationdate><title>Case study: The New Pharmacy, Part 4</title><author>Burger, Mark T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_reports_18035334803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Colon</topic><topic>Eczema</topic><topic>Enzymes</topic><topic>Food</topic><topic>Gastroesophageal reflux</topic><topic>Gluten</topic><topic>Hydrochloric acid</topic><topic>Insulin</topic><topic>Irritable bowel syndrome</topic><topic>Lipids</topic><topic>Metabolism</topic><topic>Patients</topic><topic>Probiotics</topic><topic>Proteins</topic><topic>Psoriasis</topic><topic>Studies</topic><topic>Vitamin D</topic><toplevel>online_resources</toplevel><creatorcontrib>Burger, Mark T</creatorcontrib><collection>Global News &amp; ABI/Inform Professional</collection><collection>Trade PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Career &amp; Technical Education Database</collection><collection>ABI/INFORM Complete</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection</collection><collection>ABI/INFORM Trade &amp; Industry (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Business Premium Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ABI/INFORM Professional Standard</collection><collection>ABI/INFORM Global</collection><collection>ABI/INFORM Trade &amp; Industry</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest_Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><jtitle>Drug Topics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Burger, Mark T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Case study: The New Pharmacy, Part 4</atitle><jtitle>Drug Topics</jtitle><date>2015-11-01</date><risdate>2015</risdate><volume>159</volume><issue>11</issue><spage>14</spage><pages>14-</pages><issn>0012-6616</issn><eissn>1937-8157</eissn><coden>DGTNA7</coden><abstract>[...]by fixing your digestion, we will prevent the translocation of foreign proteins through your onecell-thick colon wall into your bloodstream. [...]gel your 1,25-OH vitamin D level (goal is 50-80 ng/mL); get an HbAlc done (goal is &lt;5.3%); ask your doctor to order an Lp(a), oxidized cholesterol, and find out your ApoB-gene status." [...]look at how many surrogate markers, how much mood enhancement and metabolic balance we get just by correcting digestion: lipids, immune modulation (T-helper cell ratio/B-cell levels), psoriasis, cardiovascular (sugar damages endothelium, cholesterol rises to patch the damage); GERD; IBS-D; normalized stress hormone(s); maybe an increase in endogenous testosterone and/or increased sensitivity of T-receptors as cortisol levels normalize.</abstract><cop>Monmouth Junction</cop><pub>MultiMedia Healthcare Inc</pub></addata></record>
fulltext fulltext
identifier ISSN: 0012-6616
ispartof Drug Topics, 2015-11, Vol.159 (11), p.14
issn 0012-6616
1937-8157
language eng
recordid cdi_proquest_reports_1803533480
source Alma/SFX Local Collection
subjects Colon
Eczema
Enzymes
Food
Gastroesophageal reflux
Gluten
Hydrochloric acid
Insulin
Irritable bowel syndrome
Lipids
Metabolism
Patients
Probiotics
Proteins
Psoriasis
Studies
Vitamin D
title Case study: The New Pharmacy, Part 4
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T06%3A43%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Case%20study:%20The%20New%20Pharmacy,%20Part%204&rft.jtitle=Drug%20Topics&rft.au=Burger,%20Mark%20T&rft.date=2015-11-01&rft.volume=159&rft.issue=11&rft.spage=14&rft.pages=14-&rft.issn=0012-6616&rft.eissn=1937-8157&rft.coden=DGTNA7&rft_id=info:doi/&rft_dat=%3Cproquest%3E4115649901%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1803533480&rft_id=info:pmid/&rfr_iscdi=true